{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T17:40:27Z","timestamp":1738863627008,"version":"3.37.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.ejps.2008.12.013","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T09:39:02Z","timestamp":1230716342000},"page":"602-604","source":"Crossref","is-referenced-by-count":1,"title":["Expression of tyrosine hydroxylase in the striatum of atipamezole-treated rats"],"prefix":"10.1016","volume":"36","author":[{"given":"\u0160\u00e1rka","family":"Lehtonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pekka T.","family":"M\u00e4nnist\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atso","family":"Raasmaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2008.12.013_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00023210-199810030-00004","article-title":"Alpha(2)-adrenoceptor antagonists: a new approach to Parkinson's disease?","volume":"10","author":"Brefel-Courbon","year":"1998","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejps.2008.12.013_bib2","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0022-3565(24)38022-X","article-title":"Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway","volume":"288","author":"Chopin","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2008.12.013_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/mds.22028","article-title":"The history of dopamine and levodopa in the treatment of Parkinson's disease","volume":"2008","author":"Fahn","year":"2008","journal-title":"Movement Disord."},{"key":"10.1016\/j.ejps.2008.12.013_bib4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","article-title":"Adenosine-dopamine receptor\u2013receptor interactions as an integrative mechanism in the basal ganglia","volume":"10","author":"Ferr\u00e9","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejps.2008.12.013_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbrc.2005.07.183","article-title":"Regulatory mechanism of tyrosine hydroxylase activity","volume":"338","author":"Fujisawa","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2008.12.013_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00210-003-0827-z","article-title":"The 2-adrenoceptor antagponist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats","volume":"368","author":"Haapalinna","year":"2003","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejps.2008.12.013_bib7","first-page":"144","article-title":"Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness","volume":"2008","author":"Hornykiewicz","year":"2008","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.ejps.2008.12.013_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1353-8020(00)00007-9","article-title":"Effects of histamine H3-ligands on the levodopa-induced turning behavior of hemiparkinsonian rats","volume":"6","author":"Huotari","year":"2000","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ejps.2008.12.013_bib9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1023\/A:1006912523846","article-title":"Molecular biology of catecholamine-related enzymes in relation to Parkinson's disease","volume":"19","author":"Nagatsu","year":"1999","journal-title":"Cell. Mol. Neurobiol."},{"year":"1993","series-title":"Tyrosine Hydroxylase from Discovery to Cloning","author":"Naoi","key":"10.1016\/j.ejps.2008.12.013_bib10"},{"key":"10.1016\/j.ejps.2008.12.013_bib11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0165-6147(97)90660-X","article-title":"Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease","volume":"18","author":"Richardson","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2008.12.013_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-2999(93)90623-P","article-title":"Effects of three types of catechol-O-methylation inhibitors on l-3,4-dihydroxyphenylalanine-induced circling behavior in rats","volume":"250","author":"T\u00f6rnwall","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2008.12.013_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","article-title":"Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system","volume":"82","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ejps.2008.12.013_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejphar.2008.02.084","article-title":"Twenty years of dopamine research: individual differencies in the response of accumbal dopamine to environmental and pharmacological challenges","volume":"585","author":"Verheij","year":"2008","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098708005137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098708005137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T17:20:42Z","timestamp":1738862442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098708005137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":14,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0928098708005137"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2008.12.013","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}